Claus F. Vogelmeier

Claus F. Vogelmeier

Marburg An Der Lahn, HE, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 460 publications

Aerosol therapy during noninvasive ventilation (NIV) and nasal high-flow therapy (HFT): current technology and consensus-based recommendations.

Aerosol therapy during noninvasive ventilation (NIV) and nasal high-flow therapy (HFT): current technology and consensus-based recommendations.

Journal: Pneumologie (Stuttgart, Germany)

Published: June 19, 2026

COPD and Aspergillus-a complex interaction of global health importance.

COPD and Aspergillus-a complex interaction of global health importance.

Journal: The Lancet. Infectious diseases

Published: May 27, 2026

Title Not Found

Title Not Found

Journal: Innere Medizin (Heidelberg, Germany)

Published: April 21, 2026

Diagnostic criteria for invasive pulmonary aspergillosis in COPD patients.

Diagnostic criteria for invasive pulmonary aspergillosis in COPD patients.

Journal: American journal of respiratory and critical care medicine

Published: April 20, 2026

Astegolimab for chronic obstructive pulmonary disease with frequent exacerbations: pooled analysis of the ALIENTO and ARNASA trials.

Astegolimab for chronic obstructive pulmonary disease with frequent exacerbations: pooled analysis of the ALIENTO and ARNASA trials.

Journal: American journal of respiratory and critical care medicine

Published: April 02, 2026

Clarifying the GOLD 2026 guidance for initial pharmacological COPD treatment.

Clarifying the GOLD 2026 guidance for initial pharmacological COPD treatment.

Journal: The European respiratory journal

Published: March 13, 2026

Clinical Meaningfulness of the Composite Endpoint, COPDCompEx, in Defining Exacerbations and Worsening of COPD: A Post Hoc Analysis of 4 Clinical Interventional Studies of COPD.

Clinical Meaningfulness of the Composite Endpoint, COPDCompEx, in Defining Exacerbations and Worsening of COPD: A Post Hoc Analysis of 4 Clinical Interventional Studies of COPD.

Journal: International journal of chronic obstructive pulmonary disease

Published: March 04, 2026

Safety and efficacy of astegolimab for COPD with frequent exacerbations regardless of baseline blood eosinophil counts (ALIENTO and ARNASA): randomised, double-blind, placebo-controlled, phase 2b and 3 trials.

Safety and efficacy of astegolimab for COPD with frequent exacerbations regardless of baseline blood eosinophil counts (ALIENTO and ARNASA): randomised, double-blind, placebo-controlled, phase 2b and 3 trials.

Journal: Lancet (London, England)

Published: March 02, 2026

Tobacco and nicotine prevention-Safeguarding the future of Germany

Tobacco and nicotine prevention-Safeguarding the future of Germany

Journal: Innere Medizin (Heidelberg, Germany)

Published: February 06, 2026

Summary of Research: Dupilumab for Chronic Obstructive Pulmonary Disease with Type 2 Inflammation: A Pooled Analysis of Two Phase 3, Randomised, Double-Blind, Placebo-Controlled Trials.

Summary of Research: Dupilumab for Chronic Obstructive Pulmonary Disease with Type 2 Inflammation: A Pooled Analysis of Two Phase 3, Randomised, Double-Blind, Placebo-Controlled Trials.

Journal: Pulmonary therapy

Published: January 29, 2026

From hospital to home: Practical guidance when caring for patients with COPD and heart disease.

From hospital to home: Practical guidance when caring for patients with COPD and heart disease.

Journal: European journal of internal medicine

Published: January 26, 2026

Timely management of COPD exacerbations is associated with limited acute deterioration and early recovery: a prospective observational study.

Timely management of COPD exacerbations is associated with limited acute deterioration and early recovery: a prospective observational study.

Journal: Respiratory research

Published: January 26, 2026

Showing 1-12 of 460

Last Updated: 09/26/2026